Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Clinical trial NCT06829823 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06829823
Sponsor: ImmunityBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-muscle Invasive Bladder Cancer (NMIBC)

Start date: 2025-11-01
Primary completion: 2026-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.